| Primary |
| Prophylaxis Against Transplant Rejection |
58.7% |
| Renal Transplant |
9.3% |
| Hypertension |
6.9% |
| Immunosuppression |
4.4% |
| Immunosuppressant Drug Therapy |
3.8% |
| Liver Transplant |
3.0% |
| Heart Transplant |
1.9% |
| Diabetes Mellitus |
1.8% |
| Graft Versus Host Disease |
1.8% |
| Prophylaxis |
1.7% |
| Transplant |
1.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.0% |
| Anaemia |
0.6% |
| Blood Pressure Abnormal |
0.5% |
| Constipation |
0.5% |
| Lung Transplant |
0.5% |
| Infection Prophylaxis |
0.5% |
| Lymphangioleiomyomatosis |
0.5% |
| Hypercholesterolaemia |
0.5% |
| Kidney Transplant Rejection |
0.5% |
|
| Death |
14.1% |
| Kidney Transplant Rejection |
13.5% |
| Off Label Use |
7.3% |
| Vomiting |
6.2% |
| Transplant Rejection |
5.7% |
| Venoocclusive Liver Disease |
5.4% |
| Pyrexia |
4.5% |
| Renal Failure |
4.4% |
| Weight Decreased |
4.2% |
| Renal Failure Acute |
3.8% |
| Pneumonitis |
3.7% |
| Liver Transplant Rejection |
3.6% |
| Proteinuria |
3.6% |
| Renal Impairment |
3.6% |
| Thrombocytopenia |
3.5% |
| Pneumonia |
2.9% |
| Thrombotic Microangiopathy |
2.7% |
| Lung Disorder |
2.5% |
| Renal Tubular Necrosis |
2.5% |
| Urinary Tract Infection |
2.3% |
|
| Secondary |
| Prophylaxis Against Transplant Rejection |
38.1% |
| Renal Transplant |
11.4% |
| Hypertension |
8.8% |
| Product Used For Unknown Indication |
8.6% |
| Immunosuppression |
6.5% |
| Antiretroviral Therapy |
4.4% |
| Graft Versus Host Disease |
3.1% |
| Drug Use For Unknown Indication |
2.7% |
| Immunosuppressant Drug Therapy |
2.7% |
| Prophylaxis |
2.2% |
| Transplant |
1.9% |
| Diabetes Mellitus |
1.4% |
| Hyperlipidaemia |
1.1% |
| Liver Transplant |
1.1% |
| Prophylaxis Against Renal Transplant Rejection |
1.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.0% |
| Blood Pressure Abnormal |
1.0% |
| Hiv Infection |
1.0% |
| Neuroendocrine Carcinoma Of The Skin |
1.0% |
| Thrombosis Prophylaxis |
0.9% |
|
| Venoocclusive Liver Disease |
11.1% |
| Kidney Transplant Rejection |
8.0% |
| Transplant Rejection |
8.0% |
| Weight Decreased |
6.7% |
| Renal Impairment |
6.5% |
| Vomiting |
6.5% |
| Renal Failure Acute |
6.2% |
| Death |
4.9% |
| Renal Failure |
4.9% |
| Osteonecrosis |
4.7% |
| Pyrexia |
4.1% |
| Thrombocytopenia |
4.1% |
| Liver Transplant Rejection |
3.4% |
| Urine Colour Abnormal |
3.4% |
| Off Label Use |
3.1% |
| Pharyngitis |
3.1% |
| Pneumonitis |
3.1% |
| Premature Baby |
3.1% |
| Staphylococcal Infection |
2.6% |
| Urinary Tract Infection |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.6% |
| Drug Use For Unknown Indication |
23.6% |
| Prophylaxis Against Transplant Rejection |
7.3% |
| Renal Transplant |
5.7% |
| Hypertension |
4.6% |
| Prophylaxis |
3.3% |
| Pain |
2.8% |
| Immunosuppression |
2.6% |
| Heart Transplant |
2.5% |
| Nuclear Magnetic Resonance Imaging |
2.1% |
| Dialysis |
1.8% |
| Antiviral Prophylaxis |
1.7% |
| Liver Transplant |
1.6% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Diabetes Mellitus |
1.3% |
| Hepatic Neoplasm Malignant |
1.3% |
| Constipation |
1.3% |
| Vitamin Supplementation |
1.3% |
| Anaemia |
1.2% |
| Incision Site Pain |
1.0% |
|
| Death |
17.0% |
| Renal Impairment |
8.3% |
| Vomiting |
7.8% |
| Pyrexia |
7.3% |
| Urinary Tract Infection |
6.3% |
| Therapeutic Response Decreased |
5.3% |
| Weight Decreased |
4.9% |
| Cerebral Ischaemia |
4.4% |
| Hepatic Neoplasm Malignant |
3.9% |
| Weight Increased |
3.9% |
| Diarrhoea |
3.4% |
| Oedema Peripheral |
3.4% |
| Off Label Use |
3.4% |
| Renal Transplant |
3.4% |
| Hypertension |
2.9% |
| Renal Failure |
2.9% |
| Reticulocyte Count Decreased |
2.9% |
| Skin Hypertrophy |
2.9% |
| Suicidal Ideation |
2.9% |
| Transplant Rejection |
2.9% |
|
| Interacting |
| Prophylaxis Against Transplant Rejection |
22.1% |
| Hypertension |
11.3% |
| Immunosuppression |
8.7% |
| Lower Respiratory Tract Infection |
8.2% |
| Immunosuppressant Drug Therapy |
5.6% |
| Hiv Infection |
5.1% |
| Antiretroviral Therapy |
4.6% |
| Hypercholesterolaemia |
4.1% |
| Calcium Deficiency |
3.1% |
| Constipation |
3.1% |
| Hypertriglyceridaemia |
3.1% |
| Renal Transplant |
3.1% |
| Anxiety |
2.6% |
| Depression |
2.6% |
| Drug Use For Unknown Indication |
2.6% |
| Pain |
2.6% |
| Gastric Disorder |
2.1% |
| Prophylaxis |
2.1% |
| Renal Impairment |
2.1% |
| Contraception |
1.5% |
|
| Renal Impairment |
14.6% |
| Rhabdomyolysis |
14.6% |
| Macular Oedema |
12.2% |
| Fatigue |
7.3% |
| Immunosuppressant Drug Level Increased |
7.3% |
| Pneumonia |
7.3% |
| Transplant Rejection |
7.3% |
| Drug Interaction |
4.9% |
| Lung Disorder |
4.9% |
| Somnolence |
4.9% |
| Drug Level Increased |
2.4% |
| Hepatic Enzyme Increased |
2.4% |
| Hyperglycaemia |
2.4% |
| Proteinuria |
2.4% |
| Renal Failure Acute |
2.4% |
| Thrombocytopenia |
2.4% |
|
